Journal of Peking University (Health Sciences) ›› 2024, Vol. 56 ›› Issue (4): 565-566. doi: 10.19723/j.issn.1671-167X.2024.04.003
Previous Articles Next Articles
念增 邢*(
),明帅 王,飞亚 杨,路 尹,苏军 韩
CLC Number:
- R737.25
| 1 |
郑荣寿, 陈茹, 韩冰峰, 等. 2022年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2024, 46 (3): 221- 231.
doi: 10.3760/cma.j.cn112152-20240119-00035 |
| 2 |
Loeb S , Vellekoop A , Ahmed HU , et al. Systematic review of complications of prostate biopsy[J]. Eur Urol, 2013, 64 (6): 876- 892.
doi: 10.1016/j.eururo.2013.05.049 |
| 3 |
van der Leest M , Cornel E , Israёl B , et al. Head-to-head comparison of transrectal ultrasound-guided prostate biopsy versus multiparametric prostate resonance imaging with subsequent magnetic resonance-guided biopsy in biopsy-naïve men with elevated prostate-specific antigen: A large prospective multicenter clinical study[J]. Eur Urol, 2019, 75 (4): 570- 578.
doi: 10.1016/j.eururo.2018.11.023 |
| 4 |
Privé BM , Israёl B , Janssen MJR , et al. Multiparametric MRI and 18F-PSMA-1007 PET/CT for the detection of clinically significant prostate cancer[J]. Radiology, 2024, 311 (2): e231879.
doi: 10.1148/radiol.231879 |
| 5 |
Emmett L , Buteau J , Papa N , et al. The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (PRIMARY): A prospective multicentre study[J]. Eur Urol, 2021, 80 (6): 682- 689.
doi: 10.1016/j.eururo.2021.08.002 |
| 6 |
Xing N , Wang M , Fu Q , et al. Feasibility of prostatectomy without prostate biopsy in the era of new imaging technology and minimally invasive techniques[J]. World J Clin Cases, 2019, 7 (12): 1403- 1409.
doi: 10.12998/wjcc.v7.i12.1403 |
| 7 |
杨飞亚, 李亚健, 韩苏军, 等. 前列腺癌术前免穿刺临床应用初步探讨[J]. 中华医学杂志, 2020, 100 (34): 2658- 2662.
doi: 10.3760/cma.j.cn112137-20200104-00021 |
| 8 |
Meissner VH , Rauscher I , Schwamborn K , et al. Radical prostatectomy without prior biopsy following multiparametric magnetic resonance imaging and prostate-specific membrane antigen positron emission tomography[J]. Eur Urol, 2022, 82 (2): 156- 160.
doi: 10.1016/j.eururo.2021.11.019 |
| [1] | Yanhua LIU, Min LU, Xuyang ZHAO, Kuan'gen ZHANG, Rui WU, Fang MEI, Zhihao DAI, Jiangfeng YOU, Fei PEI. Effect of dephosphorylation of tumor metastasis suppressor gene LASS2 on vacuolar ATPase activity and invasiveness of prostate cancer [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1113-1123. |
| [2] | Xiaoyong YANG, Fan ZHANG, Lulin MA, Cheng LIU. Clinical characteristics and influencing factors of extraglandular invasion of prostatic ductal adenocarcinoma [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 956-960. |
| [3] | Jiaxin NING, Haoran WANG, Shuhang LUO, Jibo JING, Jianye WANG, Huimin HOU, Ming LIU. Multi-omics analysis of the relationship between oxidative stress-related gene and prostate cancer [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 633-643. |
| [4] | Zeyuan WANG, Shuanbao YU, Haoke ZHENG, Jin TAO, Yafeng FAN, Xuepei ZHANG. A preoperative prediction model for pelvic lymph node metastasis in prostate cancer: Integrating clinical characteristics and multiparametric MRI [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 684-691. |
| [5] | Jie LIU, Mingwei MA, Qing'an WANG, Ming SHI, Jinpeng YIN, Zhanping WANG, Jingtao SHEN, Xianshu GAO. Comparison of setup errors between two immobilization methods in prostate cancer radiotherapy based on cone-beam computed tomography [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 692-697. |
| [6] | Zhicun LI, Tianyu WU, Lei LIANG, Yu FAN, Yisen MENG, Qian ZHANG. Risk factors analysis and nomogram model construction of postoperative pathological upgrade of prostate cancer patients with single core positive biopsy [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 896-901. |
| [7] | 教悌 黄,菁 胡,博 韩. [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 557-561. |
| [8] | Yuxuan TIAN,Mingjian RUAN,Yi LIU,Derun LI,Jingyun WU,Qi SHEN,Yu FAN,Jie JIN. Predictive effect of the dual-parametric MRI modified maximum diameter of the lesions with PI-RADS 4 and 5 on the clinically significant prostate cancer [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 567-574. |
| [9] | Kaifeng YAO,Mingjian RUAN,Derun LI,Yuxuan TIAN,Yuke CHEN,Yu FAN,Yi LIU. Diagnostic efficacy of targeted biopsy combined with regional systematic biopsy in prostate cancer in patients with PI-RADS 4-5 [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 575-581. |
| [10] | Ye YAN,Xiaolong LI,Haizhui XIA,Xuehua ZHU,Yuting ZHANG,Fan ZHANG,Ke LIU,Cheng LIU,Lulin MA. Analysis of risk factors for long-term overactive bladder after radical prostatectomy [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 589-593. |
| [11] | Shuhui YU,Jianing HAN,Lijun ZHONG,Congyu CHEN,Yunxiang XIAO,Yanbo HUANG,Yang YANG,Xinyan CHE. Predictive value of preoperative pelvic floor electrophysiological parameters on early urinary incontinence following radical prostatectomy [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 594-599. |
| [12] | 蔚 薛,樑 董,宏阳 钱,笑晨 费. [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 775-780. |
| [13] | Yi LIU,Chang-wei YUAN,Jing-yun WU,Qi SHEN,Jiang-xi XIAO,Zheng ZHAO,Xiao-ying WANG,Xue-song LI,Zhi-song HE,Li-qun ZHOU. Diagnostic efficacy of prostate cancer using targeted biopsy with 6-core systematic biopsy for patients with PI-RADS 5 [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 812-817. |
| [14] | Hai MAO,Fan ZHANG,Zhan-yi ZHANG,Ye YAN,Yi-chang HAO,Yi HUANG,Lu-lin MA,Hong-ling CHU,Shu-dong ZHANG. Predictive model of early urinary continence recovery based on prostate gland MRI parameters after laparoscopic radical prostatectomy [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 818-824. |
| [15] | Chang-wei YUAN,De-run LI,Zhi-hua LI,Yi LIU,Gang-zhi SHAN,Xue-song LI,Li-qun ZHOU. Application of dynamic contrast enhanced status in multiparametric magnetic resonance imaging for prostatic cancer with PI-RADS 4 lesion [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 838-842. |
|
||